Clinically Meaningful Substance Abuse Treatment Outcome Measure for Effectiveness Trials

Agenda

 
8:30 – 9:00 a.m.Registration
  
9:00 – 9:15 a.m.Welcome and Introductory Comments
Wilson M. Compton, M.D., M.P.E.
Director
Division of Epidemiology, Services, and Prevention Research
National Institute on Drug Abuse (NIDA)

Barbara Alving, M.D.
Director
National Center for Research Resources (NCRR)
  
9:15 – 9:30 a.m. Overview of the CTSA Consortium: Current Goals and Priorities
Anthony Hayward, M.D., Ph.D.
Director
Division of Clinical Research Resources
NCRR
Presentation
  
9:30 – 10:00 a.m.Benefits of Integrating Drug Abuse Research as Part of the
CTSA Consortium Endeavor

Kathleen T. Brady, M.D., Ph.D.
Principal Investigator and Director
Southern Consortium, Clinical Trials Network
South Carolina Clinical and Translational Research Institute
Medical University of South Carolina
Presentation
  
10:00 – 10:50 a.m.Panel Discussion: Resources for Research Collaborations at CTSA Sites: The Nuts and Bolts of Establishing Research in the CTSA Context
Sergio Aguilar-Gaxiola, M.D., Ph.D.
Director of Community Engagement
Clinical and Translational Science Center
University of California, Davis
Presentation

Daniel Ford, M.D., M.P.H.
Director
The Johns Hopkins Institute for Clinical and Translational Research
Johns Hopkins School of Medicine

Philip Greenland, M.D.
Director
Northwestern University Clinical and Translational Sciences Institute
Northwestern University
Presentation

Harold Pincus, M.D.
Associate Director
Irving Institute for Clinical and Translational Research
Columbia University Medical Center

David O. Warner, M.D.
Associate Director
Center for Translational Science Activities
Mayo Clinic
Presentation

Moderator: Jeffrey D. Schulden, M.D., Medical Officer, Division of Epidemiology, Services, and Prevention Research, NIDA
  
10:50 – 11:10 a.m.Break
  
11:10 – 11:40 a.m.NIDA’s Research Priorities for the CTSA Context
Wilson M. Compton, M.D., M.P.E.
Director
Division of Epidemiology, Services, and Prevention Research
NIDA
Presentation

Mary Ellen Michel, Ph.D.
Deputy Director
Center for the Clinical Trials Network
NIDA
Presentation
  
11:40 – 1:00 p.m.Lunch (on your own)
  
1:00 – 1:30 p.m.Drug Abuse Research in Collaboration with the CTSA Consortium: Current Efforts and Future Directions
Linda B. Cottler, Ph.D., M.P.H.
Professor of Epidemiology
Director, Epidemiology and Prevention Research Group
Director, Center for Community Based Research
Washington University Institute of Clinical and Translational Sciences
Washington University in St. Louis
Presentation
  
1:30 – 2:15 p.m.Open Panel Discussion: Moving Forward – Thoughts on Building Future Drug Abuse Research in Partnership with CTSA Sites
Richard F. Catalano, Ph.D.
Bartley Dobb Professor for the Study and Prevention of Violence
Director, Social Development Research Group
School of Social Work, University of Washington
Presentation

Dennis McCarty, Ph.D.
Professor
Director, Division of Health Services Research
Department of Public Health & Preventive Medicine
Oregon Health & Science University

John S. March, M.D., M.P.H.
Director, Division of Neurosciences Medicine
Duke Clinical Research Institute
Duke University School of Medicine
Presentation

Rajita Sinha, Ph.D.
Professor of Psychiatry and Child Study
Director, Yale Stress Center
Yale School of Medicine

Moderator: Petra Jacobs, M.D., Medical Officer, Center for the Clinical Trials Network, NIDA
  
2:15 – 2:30 p.m.Break
  
2:30 – 3:45 p.m.Small Group Break-Outs – Discussion of Selected Research Concept Papers: Exploring Strategies for Building Drug Abuse Research in Cooperation with the CTSA Consortium
Moderators at each table: NIDA, NCRR, and/or CTSA Representatives
  
3:45 – 4:15 p.m.Group Debriefing on Small Group Break-Outs
Moderator: Redonna K. Chandler, Ph.D., Chief, Services Research Branch, Division of Epidemiology, Services, and Prevention Research, NIDA
  
4:15 – 4:30 p.m.Closing Remarks
Wilson M. Compton, M.D., M.P.E.
Director
Division of Epidemiology, Services, and Prevention Research
NIDA